It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Coal miners have an increased risk of pneumoconiosis. Tumor markers that are used in screening, diagnosis and follow-up of lung cancers are also useful to distinguish malignant and benign lung disorders. Carcinoembriyonic antigen, neurone specific enolase, cytokeratin 21-1 and ferritin were studied to compare and examine the possible contribution of CEA, NSE and CYFRA in the diagnosis of early and low-grade pneumoconiosis in coal miners with (34 cases) or without pneumoconiosis (27 cases). There were statistically significant differences between groups concerning NSE and ferritin levels (p<0.001, p<0.001 respectively). No difference was obtained for CYFRA 21-1 and CEA (p<0.05). The relationship of NSE with age and smoking was investigated, but no correlation was found (r=0.224, p=0.204; r=0.291, p=0.095 respecitvely). However, there was a positive correlation between NSE and exposure duration (r=0.425, p=0.012). Similarly, there was no relationship between ferritin levels and age or smoking (r=0.230, p=0.191; r=0.248, p=0.158 respectively), but there was a positive correlation with exposure duration (r=0.390, p=0.023). In conclusion, NSE and ferritin were found to be higher in coal miners with pneumoconiosis. According to these results, tumor markers are neither sensitive nor specific enough for the determination of early and low grade pneumoconiosis. One of the interesting and important findings of this study is that NSE values were higher than 12.5 µg/mL in most of the pneumoconiosis cases (%73.5). So, the NSE cut-off value used in cancer screening of coal workers with pneumoconiosis should increased.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer